Home
Medical and Surgical Clinical Outcome Review Programme
Health

Medical and Surgical Clinical Outcome Review Programme

Friday, 28 June 2019, 8:27

Medical and Surgical Clinical Outcome Review Programme

HQIP manage the Medical and Surgical Clinical Outcome Review Programme on behalf of NHS England, Welsh Government, the Scottish Government, the Northern Ireland Department of Health and the States of Jersey, Guernsey, and the Isle of Man as part of the National Clinical Audit and Patient Output Programme.

United Kingdom-London: Health services

2019/S 121-296854

Contract notice

Services

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses

Healthcare Quality Improvement Partnership (HQIP)
Dawson House, 5 Jewry Street
London
EC3N 2EX
United Kingdom
Contact person: Nicholas Holmes
E-mail: procurement@hqip.org.uk
NUTS code: UK

Internet address(es):Main address: http://www.hqip.org.uk/

Address of the buyer profile: http://www.hqip.org.uk/tenders

I.2)Information about joint procurement

I.3)Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at: http://redirect.transaxions.com/events/BGiZZ
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted electronically via: http://redirect.transaxions.com/events/BGiZZ

I.4)Type of the contracting authority

Other type: HQIP is a Company Ltd by Guarantee and a Registered Charity in England and Wales commissioning on behalf of NHS England and the Health Departments of the UK Devolved Nations who wish to participate

I.5)Main activity

Health

Section II: Object

II.1)Scope of the procurement

II.1.1)Title:

Medical and Surgical Clinical Outcome Review Programme

Reference number: HQIP NCA 2061

II.1.2)Main CPV code

85100000

II.1.3)Type of contract

Services

II.1.4)Short description:

HQIP manage the Medical and Surgical Clinical Outcome Review Programme on behalf of NHS England, Welsh Government, the Scottish Government, the Northern Ireland Department of Health and the States of Jersey, Guernsey, and the Isle of Man as part of the National Clinical Audit and Patient Output Programme (NCAPOP). The medical and surgical clinical outcome review programme is 1 of 4 clinical outcome review programmes (previously known as confidential enquiries). The work of the programme also complements and contributes to the work of other agencies such as NICE, the Care Quality Commission (CQC), the Royal Colleges and academia that can help improve the quality and safety of healthcare delivery.

The successful bidder will build on the experiences and achievements of the programme since its inception.

II.1.5)Estimated total value

Value excluding VAT: 2 388 765.00 GBP

II.1.6)Information about lots

This contract is divided into lots: no
II.2)Description
II.2.1)Title:

II.2.2)Additional CPV code(s)

85121200
85140000
85148000

II.2.3)Place of performance

NUTS code: UK

II.2.4)Description of the procurement:

Full details of the Authority’s requirements are set out in the specification document.

Please follow the link to view the specification and to formally express your interest in this contract opportunity. Potential providers must complete the supplier registration form and declaration on the system and submit for approval before they can access the Invitation to Tender (ITT) which is a separate event.

NB: This is a one stage process and the deadline given for the submission of complete tenders is the same as expressions of interest.

II.2.5)Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.6)Estimated value

Value excluding VAT: 2 388 765.00 GBP

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 36
This contract is subject to renewal: yes
Description of renewals:

There is potential to extend the contract for up to 2 additional years, subject to topic prioritisation by the funders,the availability of funding and an assessment by HQIP on the quality of the delivery of the programme.

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: yes
Description of options:

The contract is let initially to be delivered for NHS-funded care in England, Wales, Scotland and Northern Ireland for a period of 3 years, at a maximum total budget of up to 2 388 765 GBP excluding VAT and bids exceeding this limit will be rejected. In addition, the States of Jersey and Guernsey, and the Isle of Man, may join the programme at a later date although this is yet to be confirmed. The additional contract value that would be offered to support the participation of the States of Jersey and Guernsey, and the Isle of Man would be 3 080 GBP per annum pro rata excl. VAT. If the States of Jersey and Guernsey, and the Isle of Man joined early in the first year and the whole contract was then extended to the 5 years’ total duration, subject to topic prioritisation by the funders, the availability of funding and an assessment by HQIP on the quality of the delivery of the programme, the maximum contract value would be 3 996 000 GBP excl. VAT. The contract is anticipated to start on 1.4.2020.

Potential future aspirational intent:

The future aspirational intention of this opportunity is to potentially include:

— different topics,

— combining NCAPOP projects/programmes.

Extending service coverage to include additional countries and/or devolved nations if they were to buy into the programme and their data needed to be included in the work to be carried out. For the avoidance of doubt, the term devolved nation refers to any body which has had powers relating to health services devolved to it by the Parliament of the United Kingdom, including but not limited to Scotland, Wales, Northern Ireland, Jersey, Guernsey and the Isle of Man.

Extending service coverage to include non-NHS funded car.e

Additional, associated or enhanced delivery of any aspect of the Medical and Surgical Clinical Outcome Review Programme.

Other quality improvement initiatives either related to or linked with the project.

Please note, there is no commitment by the Authority at this stage to include any of these. Taking this aspirational intent into account as well as the possibility that a contract extension may be offered for an additional 2 years, the potential ceiling value is 7 000 000 GBP excluding VAT.

NB: Bidders should submit their schedule of offer based on ‘core’ delivery for the initial 3 years only. The maximum budget ‘core’ value is 2 388 765 GBP excluding VAT. This excludes the aspirational intent elements listed above.

II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

II.2.14)Additional information

HQIP uses an e-procurement system.

Section III: Legal, economic, financial and technical information

III.1)Conditions for participation

III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

List and brief description of conditions:

This procurement exercise will be conducted via the Authority’s e-tendering portal.

There will be no hard copy documents issued to potential providers and all communications between potential providers and the Authority, including tender submissions will be through the e-tendering portal.

III.1.2)Economic and financial standing

List and brief description of selection criteria:

As per the ITT.

III.1.3)Technical and professional ability

List and brief description of selection criteria:

As per the ITT.

III.1.5)Information about reserved contracts
III.2)Conditions related to the contract
III.2.1)Information about a particular profession

III.2.2)Contract performance conditions:

As per acceptance of HQIP standard terms and conditions of contract.

Any subsequent contract award will include a performance related pay element linked to the achievement of key contract deliverables which will be mutually agreed with the successful bidder.

III.2.3)Information about staff responsible for the performance of the contract

Section IV: Procedure

IV.1)Description

IV.1.1)Type of procedure

Open procedure
IV.1.3)Information about a framework agreement or a dynamic purchasing system
IV.1.4)Information about reduction of the number of solutions or tenders during negotiation or dialogue
IV.1.6)Information about electronic auction

IV.1.8)Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: no
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure

IV.2.2)Time limit for receipt of tenders or requests to participate

Date: 15/08/2019
Local time: 12:00
IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates

IV.2.4)Languages in which tenders or requests to participate may be submitted:

English

IV.2.6)Minimum time frame during which the tenderer must maintain the tender

Tender must be valid until: 13/12/2019

IV.2.7)Conditions for opening of tenders

Date: 15/08/2019
Local time: 12:00

Section VI: Complementary information

VI.1)Information about recurrence

This is a recurrent procurement: no

VI.2)Information about electronic workflows

Electronic payment will be used
VI.3)Additional information:
VI.4)Procedures for review

VI.4.1)Review body

Healthcare Quality Improvement Partnership
Dawson House, 5 Jewry Street
London
EC3N 2EX
United Kingdom
E-mail: procurement@hqip.org.ukInternet address: www.hqip.org.uk
VI.4.2)Body responsible for mediation procedures
VI.4.3)Review procedure
VI.4.4)Service from which information about the review procedure may be obtained

VI.5)Date of dispatch of this notice:

25/06/2019